Chiron Corp.’s John Lambert, president of the company’s vaccine unit, resigned after contamination at a plant in England caused a shortage of influenza shots in the U.S during the 2004-05 season.

Chiron still has a hurdle to climb before it can begin to re-supply its flu vaccine, Fluvirin, to the USA, according to a statement from the US Food and Drug Administration yesterday. Chiron still has ...

Chiron Corp., which was forced to scrap its entire inventory of flu vaccine last year and triggered a U.S. public health crisis, got approval to re-enter the flu shot market Wednesday as drug ...

Chiron Corp. received clearance to begin producing its flu vaccine again. The Emeryville, Calif.-based company, which last year lost its license to manufacture Fluvirin, received word that the UK's ...

-- Novartis plans to ship more than 30 million doses of Fluvirin vaccine to US customers for 2012-2013 season with sufficient supply to meet customer needs During each season, influenza may cause ...

Chiron Corporation announced that, in conducting final internal release procedures for its Fluvirin influenza virus vaccine, the company's quality systems have identified a small number of lots that ...

EMERVILLE, Calif., Oct. 12 (UPI) -- Chiron Corp. in Emerville, Calif., said Tuesday it received a grand jury subpoena requesting information on Fluvirin. The drug-maker also said the subpoena is ...

The Food and Drug Administration approved three lots of Chiron's flu vaccine Fluvirin for general distribution, easing fears of a possible vaccine shortage for the 2005 flu season. The approval means ...

Pien told a conference call yesterday that the extent of the changes that Chiron had to make at its manufacturing facility for Fluvirin in Liverpool, UK [ [06/10/04b]], meant that the company got ...

NEW YORK (MarketWatch) -- Morgan Stanley said the potential return of Chiron's flu vaccine FluVirin to the U.S. market would be a "major positive" for healthcare products distributor Henry Schein .

-- Novartis plans to ship more than 30 million doses of Fluvirin vaccine to US customers for 2012-2013 season with sufficient supply to meet customer needs -- Early delivery allows for timely ...